Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Titration in Cardiac Surgery
NCT05246397Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2022
- Primary completion
- Nov 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University of Washington. Started Feb 2022; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05246397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05246397.